Skip to main content

New Jersey

Public Health Trace has 21,683 recall records and 273 outbreak investigations on file connected to New Jersey, with 7,706 reported illnesses across those outbreak investigations, republished from official FDA, USDA, and CDC sources.

21,683
Recalls distributed here
273
Outbreaks affecting this state
7,706
Reported illnesses
Recalls and outbreaks by year

A bar chart of recall and outbreak counts affecting this state by year, built from the complete yearly totals for this state, not a bounded preview.

  • Recalls
  • Outbreaks
Download CSV
View full recalls and outbreaks by year (56 years)
Recalls and outbreaks by year
YearRecallsOutbreaks
197102
197200
197303
197401
197503
197601
197701
197800
197900
198000
198100
198200
198300
198400
198501
198600
198700
198800
198903
199000
199100
199202
199301
199403
199500
199601
199700
1998013
1999017
200004
2001013
2002010
2003010
2004020
200507
2006010
2007014
200809
2009015
2010014
2011012
201239916
20131,15310
201470917
20151,75211
20161,7454
20172,2574
20181,5038
20192,30113
20201,1950
20211,0080
20222,0360
20232,1840
20241,2370
20251,1540
20261,0500

CDC NORS is a historical archive currently available through 2023; later zeros do not mean no outbreaks occurred.

Recall records distributed in New Jersey

Newest reported records first. Each record's own status (active, terminated, or not reported) is shown on its card.

FDA Recall Ongoing2026 recordClass II

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

by Apotex Corp.

Reason
Failed dissolution specifications.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

by Par Health USA, LLC

Reason
Crystallization
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

by TerSera Therapeutics LLC

Reason
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.

by Amneal Pharmaceuticals, LLC

Reason
Defective Container; packets were found to be either empty or partially full.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

by Ajanta Pharma USA Inc

Reason
Failed Dissolution Specifications: below specification
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass I

TODD'S SEEDS LLC

Product
Todd's Seeds Variety Pack of Sprouting Seeds - Broccoli, Alf…
Reason
Products contain alfalfa seed recalled by the supplier and may be contaminated with E. coli and/or Salmonella (downstream recall)
Published
October 7, 2026
Distribution
Nationwide

View recall →

Showing 6 of 21,683 recall records

See all recalls in New Jersey

Outbreak records affecting New Jersey

Newest reported records first. Each record's own status (active investigation, historical, or monitoring) is shown on its card.

Showing 6 of 273 outbreak records

See all outbreaks in New Jersey

Companies with recalls distributed in New Jersey

Via the real distribution-state record on each recall -- distinct from the free-text match used for the recall cards above.

CDC announcements naming New Jersey

Only announcements with an explicit, normalized relationship to New Jersey are shown -- see our methodology.

Disease surveillance trends

No disease surveillance trend data has been published for this state.

Data availability

Disease surveillance trends are only shown where CDC's reporting areas have been matched to this state. A state showing no surveillance data here may still have real recalls and outbreaks above - the gap is in state-level linkage for weekly case reports specifically, not an indication that nothing was reported.

Freshness unavailable for one or more included sources

This page combines recall records from the FDA and USDA with outbreak investigations and disease surveillance data from the CDC. It is not a safety ranking or comparison between states -- a higher count here can reflect more thorough reporting as much as more actual events, and is not a statement that New Jersey is more or less safe than any other state. Read the full medical disclaimer.